Evidence map›Paper›PMID 41002430›Full record

ArticleCells2025

Maria Rojo-Pardillo, Alice Augenlicht, Geneviève Dom, Jukka Kero, Bernard Robaye, Carine Maenhaut

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cells, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Maria Rojo-PardilloIRIBHM J. E. Dumont, Université Libre de Bruxelles,1070 Brussels, Belgium.ORCID 0009-0003-8699-6514
Alice AugenlichtIRIBHM J. E. Dumont, Université Libre de Bruxelles,1070 Brussels, Belgium.
Geneviève DomIRIBHM J. E. Dumont, Université Libre de Bruxelles,1070 Brussels, Belgium.
Jukka KeroDepartment of Clinical Sciences, Faculty of Medicine, University of Turku, FI-20520 Turku, Finland.ORCID 0000-0001-8767-7222
Bernard RobayeIRIBHM J. E. Dumont, Université Libre de Bruxelles, Campus Charleroi, 6041 Charleroi, Belgium.
Carine MaenhautIRIBHM J. E. Dumont, Université Libre de Bruxelles,1070 Brussels, Belgium.

Funding

David et Alice Van Buuren FoundationFund for Scientific Research - FRIA grant FC36079Fund for Scientific Research - Research credit CDR J.0123.23Fund for Scientific Research - Research credit CDR J.0150.25Héger-Masson FoundationJaumotte-Demoulin FoundationKing Baudouin Foundation - Fund Doctor J.P. Naets 2023-J1813300-233020King Baudouin Foundation - Fund Doctor J.P. Naets 2025-J1813300-0025101Rose et Jean Hoguet Foundation
6 · The paper itself

Abstract

Beyond well-known genetic drivers, microRNA dysregulation has emerged as a key contributor to thyroid tumorigenesis. Central to this process is

Indexed as

DEAD-box RNA HelicasesDNA DamageProto-Oncogene Proteins c-retRibonuclease IIIThyroid Cancer, PapillaryThyroid NeoplasmsAnimalsCell DeathDisease Models, AnimalDisease ProgressionHumansMiceMice, TransgenicDEAD-box RNA HelicasesDicer1 protein, mouseProto-Oncogene Proteins c-retRibonuclease IIIDicer1papillary thyroid cancerRET/PTC3thyroid

Identifiers

PMID41002430
PMCPMC12468101

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.